Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterium protein tyrosine phosphatase B (mPTPB), also known as PtpB, is a secreted enzyme produced by *Mycobacterium tuberculosis* (Mtb). It is an essential virulence factor that modulates host signaling pathways to promote bacterial survival inside macrophages. It exhibits triple-specificity phosphatase activity and dephosphorylates tyrosine, serine, and threonine residues. mPTPB subverts innate immune responses, blocks ERK1/2 and p38 MAP kinase-mediated IL-6 production, and promotes host cell survival via Akt pathway activation. It is a validated drug target with inhibitors showing promise as anti-TB agents.
Selective inhibition of mPTPB activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium protein tyrosine phosphatase B (None).